申请人:——
公开号:US20040162435A1
公开(公告)日:2004-08-19
The present invention relates to aliphatic compounds of the formula I, or stereoisomers thereof, or their pharmaceutically acceptable salts:
1
wherein A represents an optionally substituted CH
3
C
n
H
(2n−2m)
— (wherein n denotes an integer of 4 to 22, and m represents an unsaturation number which is an integer of 0 to 7), 1 represents an integer of 0 to 10, s represents 0 or 1, provided that when s is 0, p+q=4 or 5, but when s is 1, p+q=3 or 4, and in each case, either p or q is an integer of 1 or more, R represents an alkyl group having 1 to 10 carbon atoms which may be straight-chain or branched-chain, and R
A
represents hydrogen or an alkyl group having 1 to 10 carbon atoms which may be straight-chain or branched-chain, and their use in suppression of platelet aggregation, in suppression of inflammation, and in prevention and treatment of circulatory diseases.
本发明涉及公式I的脂肪族化合物,或其立体异构体,或其药学上可接受的盐:1其中,A代表可选择取代的CH3CnH(2n-2m)-(其中n为4至22的整数,m表示0至7的不饱和度数),1代表0至10的整数,s代表0或1,但当s为0时,p+q=4或5,而当s为1时,p+q=3或4,并且在每种情况下,p或q都是1或更多的整数,R代表具有1至10个碳原子的烷基基团,可以是直链或支链,RA代表氢或具有1至10个碳原子的烷基基团,可以是直链或支链,并且它们的用途是抑制血小板聚集,抑制炎症,并预防和治疗循环系统疾病。